Searched for
SHASUN
- Buy Shasun Pharma with a target of Rs 445: Prakash Gaba"Shasun Pharma is a 'BUY' call with a target of Rs 445 and a stop loss of Rs 415."
Shasun Pharma gets US FDA nod to market CarisoprodolShasun Pharmaceuticals said the product will be manufactured at its Puducherry plant and distributed through a partner.- Buy Shasun Pharma Ltd with a target of Rs 386: Mitesh Thacker'Shasun Pharma Ltd is a 'BUY' call with a target of Rs 386 and a stop loss of Rs 354'
- CCI gives green signal to merger of Shasun Pharma with StridesThe combination of Strides and Shasun would create a company with a turnover of Rs 2,500 crore, placing the combined entity among the top 1...
- Shasun gets shareholder nod for merger with Strides ArcolabShareholders of Shasun Pharmaceuticals have approved its merger proposal with drug firm Strides Arcolab.
- Shasun Pharmaceuticals seeks shareholder nod for merger with Strides ArcolabIn a filing to the BSE, Shasun Pharmaceuticals said it is seeking shareholders nod for the merger scheme through a postal ballot.
- Buy Shasun Pharma with a target of Rs 228: Ashwani Gujral"Shasun Pharma is a 'BUY' call with a target of Rs 228 and a stop loss of Rs 212."
- Strides Arcolab shares gain 9% on merger with Shasun PharmaShares of Strides Arcolab gained over 9 per cent today after the company and Shasun Pharmaceuticals announced their merger .
- Strides, Shasun announce merger; to create Rs 2,500 crore entityBased on the exchange ratio, Shasun shareholders will own 26 per cent of the combined entity.
- Strides Arcolab approves merger with Shasun Pharma; stock gainsShasun Pharma will amalgamate with Strides in an all-stock transaction. Shasun shareholders will get 5 shares of Strides for every 16 share...
- Buy Shasun Pharmaceuticals Ltd with a target of 212: Ashwani Gujral'Shasun Pharmaceuticals Ltd is a 'BUY' call with a target of Rs 212 and a stop loss of Rs 195.'
- Buy Shasun Pharmaceuticals Ltd with a target of Rs 142: Ashwani GujralShasun Pharmaceuticals Ltd is a 'buy' call with a target of Rs 142 and a stop loss of Rs 120.
- Buy Shasun Pharma with target price of Rs 98: Sandeep WagleShasun Pharma is a 'BUY' call with a target of Rs 98 and a stop loss of Rs 83.
- Shasun inks pact with SeQuent Scientific to form joint ventureSeQuent and Shasun will hold 73% and 27% stakes respectively in the firm, which is expected to be operational in the first quarter of 2014-...
- Buy Shasun Pharma with a target of Rs 90: Ashwani Gujral"Shasun Pharma Ltd is a ‘BUY’ call with a target of Rs 90 and a stop loss of Rs 76."
- Shasun Pharmaceuticals in licensing pact with Swiss-based DebiopharmShasun Pharmaceuticals would be able to use the Debiopharm technology for manufacturing synthetic Huperzine-A and commercialise it.
- Buy Shasun Pharmaceuticals with target of Rs 182: Ashwani GujralBuy Shasun Pharmaceuticals with a target of Rs 182 and a stop loss of Rs 174.
- Buy Shasun Pharma: Prakash Gaba"I like Shasun Pharma that has bottomed out. It seems that Shasun Pharma has a very-very strong support at around these levels of 157."
- Buy Shasun Pharma with a target of 171: Deepak MohoniShasun Pharma Ltd is a ‘BUY’ call with a target of Rs 171 and a stop loss of Rs 162.
- Accumulate Shasun Pharma on dips: CK Narayan"I like what I see on the charts on Shasun but I would like it more if it were to fall down to somewhere around odd 70 levels. "
Load More
